ROVI will present positive results of Risperidone ISM® and Bemiparin at the 12th EACPT Congress


No votes yet
 
Related
0 min
25/09/2020
ROVI obtains second place in a global sustainability rating
ROVI participated voluntarily in this rating, which measures the sustainability of companies based on criteria such as corporate governance...
1 min
25/09/2020